| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 4 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 |
| 2 | TACROLIMUS OINTMENT 0.1% | 4 |
| 3 | AZACITIDINE | 3 |
| 4 | AZACITIDINE FOR | 3 |
| 5 | BLEOMYCIN | 3 |
| 6 | BLEOMYCIN SULFATE | 3 |
| 7 | BLINATUMOMAB | 3 |
| 8 | CYTARABINE | 3 |
| 9 | DASATINIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DUVELISIB | 3 | 0.0035 |
| 1 | DECITABINE | 3 | 0.0007 |
| 2 | PONATINIB HYDROCHLORIDE | 3 | 0.0006 |
| 3 | DASATINIB | 3 | 0.0003 |
| 4 | BLEOMYCIN SULFATE | 3 | 0.0003 |
| 5 | BLINATUMOMAB | 3 | 0.0003 |
| 6 | SIROLIMUS | 3 | 0.0002 |
| 7 | MELPHALAN HYDROCHLORIDE | 3 | 0.0001 |
| 8 | NILOTINIB | 3 | 0.0001 |
| 9 | AZACITIDINE | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Iron Chelator [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 3 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |